BioPharm International
December 01, 2018
Peer-Reviewed Research
31
12
This research proposes a method for separating and purifying tissue-type plasminogen activator from a fungal cell source.
December 01, 2018
Feature
31
12
Unprocessed bulk material harvested directly from the bioreactor should be tested for contamination prior to downstream processing.
December 01, 2018
Ask the Expert
31
12
A required time frame should not be the driving force behind root cause investigations, says Susan Schniepp, executive vice-president of Post-Approval Pharma and Distinguished Fellow, Regulatory Compliance Associates.
December 01, 2018
Features
31
12
Bioconjugation requires aseptic manufacturing and containment for cytotoxic payloads.
December 01, 2018
Features
31
12
CMOs and CDMOs made investments in new and expanded facilities and services in the last quarter of 2018.
December 01, 2018
Cover Story
31
12
Success depends on supplier communication and transparency, but it’s up to buyers to demand the right information and to look at the vendor’s overall business.
December 01, 2018
Issue PDF
31
12
Click the title above to open the BioPharm International December 2018 issue in an interactive PDF format.
December 01, 2018
Features
31
12
Fluorescence has long been used to detect biological targets. As these measurements are becoming more and more quantitative, standards are needed to ensure accuracy and reproducibility.
December 01, 2018
From the Editor
31
12
Innovation may capture headlines, but quality programs are the foundation to biopharma success.
December 01, 2018
Features
31
12
Advances in single-use technologies, sensors, and cell retention systems facilitate processes designed for the long run.
November 29, 2018
Regulatory Beat
31
12
Despite ongoing efforts to address the problem, FDA now sees a rise in active shortages and in the duration of supply problems.